Skip to main content
. Author manuscript; available in PMC: 2013 Jun 10.
Published in final edited form as: Clin Trials. 2007;4(5):548–559. doi: 10.1177/1740774507083388

Table 2.

Strength of evidence of intermediate endpoints

Intermediate endpoint Associated with depression Associated with CHD outcomes Improved with exercise Improved with SSRIs
Heart rate variability + + + + + + + −/?
Baroreflex control + ++ + +
Flow mediated dilation + + + + + ?
Inflammation + + ++ + ?
Platelet activity + + + + + ++

−=not related;? = few studies have addressed; + = preliminary evidence; + + = some evidence; + + + = strong evidence.